Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcutis Biotherapeutics (ARQT) Change in Inventory (2022 - 2025)

Arcutis Biotherapeutics has reported Change in Inventory over the past 4 years, most recently at $5000.0 for Q4 2025.

  • Quarterly results put Change in Inventory at $5000.0 for Q4 2025, down 98.11% from a year ago — trailing twelve months through Dec 2025 was $7.3 million (up 1732.25% YoY), and the annual figure for FY2025 was $7.3 million, up 1732.25%.
  • Change in Inventory for Q4 2025 was $5000.0 at Arcutis Biotherapeutics, down from $5.9 million in the prior quarter.
  • Over the last five years, Change in Inventory for ARQT hit a ceiling of $5.9 million in Q3 2025 and a floor of -$779000.0 in Q4 2023.
  • Median Change in Inventory over the past 4 years was $835000.0 (2023), compared with a mean of $1.5 million.
  • Peak annual rise in Change in Inventory hit 1626.55% in 2025, while the deepest fall reached 181.83% in 2025.
  • Arcutis Biotherapeutics' Change in Inventory stood at $3.2 million in 2022, then plummeted by 124.29% to -$779000.0 in 2023, then surged by 134.02% to $265000.0 in 2024, then tumbled by 98.11% to $5000.0 in 2025.
  • The last three reported values for Change in Inventory were $5000.0 (Q4 2025), $5.9 million (Q3 2025), and -$518000.0 (Q2 2025) per Business Quant data.